News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Nguyen Tran
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
4
| Nguyen Tran (Director) has filed a Form 4 on Rain Oncology Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.21, valued at
$42.4k
|
|
| 05/17/2023 |
4
| Nguyen Tran (Chief Strategy Officer and CFO) has filed a Form 4 on PROTHENA CORP PUBLIC LTD CO|
Txns:
| Sold 14,001 shares
@ $72.6609, valued at
$1M
Sold 34,640 shares
@ $73.5367, valued at
$2.5M
Sold 37,044 shares
@ $74.5458, valued at
$2.8M
Sold 9,215 shares
@ $75.4429, valued at
$695.2k
Sold 100 shares
@ $76.04, valued at
$7.6k
Exercised 45,000 options to buy
@ $29.81, valued at
$1.3M
Exercised 50,000 options to buy
@ $22.85, valued at
$1.1M
|
|
| 05/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2023 |
4
| Nguyen Tran (Chief Strategy Officer and CFO) has filed a Form 4 on PROTHENA CORP PUBLIC LTD CO|
Txns:
| Granted 48,000 options to buy
@ $52.97, valued at
$2.5M
|
|
| 01/20/2023 |
4
| Nguyen Tran (Chief Strategy Officer and CFO) has filed a Form 4 on PROTHENA CORP PUBLIC LTD CO|
Txns:
| Sold 7,277 shares
@ $55.177, valued at
$401.5k
Sold 2,085 shares
@ $56.3242, valued at
$117.4k
Sold 638 shares
@ $56.9709, valued at
$36.3k
Exercised 10,000 options to buy
@ $6.73, valued at
$67.3k
|
|
| 12/23/2022 |
4
| Nguyen Tran (Chief Strategy Officer and CFO) has filed a Form 4 on PROTHENA CORP PUBLIC LTD CO|
Txns:
| Sold 3,155 shares
@ $58.4551, valued at
$184.4k
Sold 6,845 shares
@ $59.2059, valued at
$405.3k
Exercised 10,000 options to buy
@ $6.73, valued at
$67.3k
|
|
| 11/25/2022 |
4
| Nguyen Tran (Chief Strategy Officer and CFO) has filed a Form 4 on PROTHENA CORP PUBLIC LTD CO|
Txns:
| Sold 4,547 shares
@ $60.5324, valued at
$275.2k
Sold 3,984 shares
@ $61.2764, valued at
$244.1k
Sold 1,469 shares
@ $62.2788, valued at
$91.5k
Exercised 10,000 options to buy
@ $6.73, valued at
$67.3k
|
|
| 10/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2022 |
4
| Nguyen Tran (Chief Strategy Officer and CFO) has filed a Form 4 on PROTHENA CORP PUBLIC LTD CO|
Txns:
| Sold 10,000 shares
@ $30.7496, valued at
$307.5k
Exercised 10,000 options to buy
@ $6.73, valued at
$67.3k
|
|
| 08/26/2022 |
4
| Nguyen Tran (Chief Strategy Officer and CFO) has filed a Form 4 on PROTHENA CORP PUBLIC LTD CO|
Txns:
| Sold 10,000 shares
@ $30.1672, valued at
$301.7k
Exercised 10,000 options to buy
@ $6.73, valued at
$67.3k
|
|
| 08/19/2022 |
4
| Nguyen Tran (Director) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.44, valued at
$48.8k
|
|
| 07/22/2022 |
4
| Nguyen Tran (Chief Strategy Officer and CFO) has filed a Form 4 on PROTHENA CORP PUBLIC LTD CO|
Txns:
| Sold 25,136 shares
@ $32.3249, valued at
$812.5k
Sold 16,984 shares
@ $32.7321, valued at
$555.9k
Sold 20,555 shares
@ $32.6405, valued at
$670.9k
Sold 5 shares
@ $33.69, valued at
$168.5
Sold 7,320 shares
@ $32.5483, valued at
$238.3k
Exercised 42,120 options to buy
@ $6.73, valued at
$283.5k
Exercised 20,560 options to buy
@ $6.73, valued at
$138.4k
Exercised 7,320 options to buy
@ $6.73, valued at
$49.3k
|
|
| 02/25/2022 |
4
| Nguyen Tran (Chief Strategy Officer and CFO) has filed a Form 4 on PROTHENA CORP PUBLIC LTD CO|
Txns:
| Granted 85,000 options to buy
@ $32.45, valued at
$2.8M
|
|
| 04/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/26/2021 |
4
| Nguyen Tran (See Remarks) has filed a Form 4 on PROTHENA CORP PUBLIC LTD CO|
Txns:
| Granted 84,000 options to buy
@ $22.6, valued at
$1.9M
|
|
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2019 |
4
| Nguyen Tran (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 30,000 options to buy
@ $0.66, valued at
$19.8k
|
|
| 03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2018 |
4
| Nguyen Tran (COO and CFO) has filed a Form 4 on Prothena Corp plc|
Txns:
| Granted 250,000 options to buy
@ $15.04, valued at
$3.8M
|
|
| 06/14/2018 |
4
| Nguyen Tran (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.27, valued at
$81.8k
|
|
| 02/23/2018 |
4
| Nguyen Tran (CFO) has filed a Form 4 on Prothena Corp plc|
Txns:
| Granted 80,000 options to buy
@ $33.1, valued at
$2.6M
|
|
| 06/14/2017 |
4
| Nguyen Tran (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.13, valued at
$28.3k
|
|
| 03/09/2017 |
4
| Nguyen Tran (CFO) has filed a Form 4 on Prothena Corp plc |
| 02/24/2017 |
4
| Nguyen Tran (CFO) has filed a Form 4 on Prothena Corp plc |
| 06/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/24/2016 |
3
| Nguyen Tran (Director) has filed a Form 3 on ProNAi Therapeutics Inc |
| 02/26/2016 |
4
| Nguyen Tran (CFO) has filed a Form 4 on Prothena Corp plc|
Txns:
| Granted 65,000 options to buy
@ $34.61, valued at
$2.2M
|
|
| 12/11/2015 |
4
| Nguyen Tran (CFO) has filed a Form 4 on Prothena Corp plc|
Txns:
| Sold 8,169 shares
@ $65.4616, valued at
$534.8k
Sold 19,731 shares
@ $66.3684, valued at
$1.3M
Sold 2,100 shares
@ $67.0021, valued at
$140.7k
Exercised 30,000 options to buy
@ $6.73, valued at
$201.9k
|
|
| 03/12/2015 |
4
| Nguyen Tran (CFO) has filed a Form 4 on Prothena Corp plc|
Txns:
| Granted 55,000 options to buy
@ $27.81, valued at
$1.5M
|
|
| 05/12/2014 |
4
| Nguyen Tran (CFO) has filed a Form 4 on Prothena Corp plc|
Txns:
| Bought 2,200 shares
@ $19.6064, valued at
$43.1k
|
|
| 02/06/2014 |
4
| Nguyen Tran (CFO) has filed a Form 4 on Prothena Corp plc|
Txns:
| Granted 45,000 options to buy
@ $29.81, valued at
$1.3M
|
|
| 04/02/2013 |
4
| Nguyen Tran (CFO) has filed a Form 4 on Prothena Corp plc|
Txns:
| Granted 180,000 options to buy
@ $6.73, valued at
$1.2M
|
|
|
|
|